Evaluations of bioantioxidants in cryopreservation of umbilical cord blood using natural cryoprotectants and low concentrations of dimethylsulfoxide

Cryobiology

Volumn 60, Issue 3, 2010, Pages 301-307

  Motta, J P R ^a,b   Gomes, B E ^b   Bouzas, L F ^b   Paraguassu Braga F H ^b   Porto, L C ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Ascorbic acid; Catalase; CD123+; CD34+; Cord blood; Cryopreservation; Me2SO; Sucrose; Trehalose

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; DISACCHARIDE; REACTIVE OXYGEN METABOLITE; SUCROSE; TREHALOSE;

ARTICLE; CD34 SELECTION; CELL DAMAGE; CELL DEATH; CELL VIABILITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; FREEZE THAWING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RISK REDUCTION; UMBILICAL CORD BLOOD;

ANTIOXIDANTS; BLOOD PRESERVATION; CATALASE; CELL SEPARATION; CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; DISACCHARIDES; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; STEM CELLS; SUCROSE; TREHALOSE;

EID: 77952674669     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2010.02.002     Document Type: Article

References (44)

1. Acker J.P., Lu X.M., Young V., Cheley S., Bayley H., Fowler A., Toner M. Measurement of trehalose loading of mammalian cells porated with a metal-actuated switchable pore. Biotechnol. Bioeng. 2003, 82:525-532.
2. Alessandrino P., Bernasconi P., Caldera D., Colombo A., Bonfichi M., Malcovati L., Klersy C., Martinelli G., Maiocchi M., Pagnucco G., Varettoni M., Perotti C., Bernasconi C. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant. 1999, 23:533-537.
3. Anchordoguy T.J., Rudolph A.S., Carpenter J.F., Crowe J.H. Modes of interaction of cryoprotectants with membrane phospholipids during freezing. Cryobiology 1987, 24:324-331.
4. Bender J.G., Unverzagt K. Flow cytometric analysis of peripheral blood stem cells. J. Hematother. 1993, 2:421-430.
5. Buchanan S.S., Gross S.A., Acker J.P., Toner M., Carpenter J.F., Pyatt D.W. Cryopreservation of stem cells using trehalose: evaluation of the method using a human hematopoietic cell line. Stem Cells Dev. 2004, 13:295-305.
6. Buettner G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 1993, 300:535-543.
7. Chen T., Acker J.P., Eroglu A., Cheley S., Bayley H., Fowler A., Toner M. Beneficial effect of intracellular trehalose on the membrane integrity of dried mammalian cells. Cryobiology 2001, 43:168-181.
8. Crowe L.M., Crowe J.H. Anhydrobiosis: a strategy for survival. Adv. Space Res. 1992, 12:239-247.
9. Crowe J.H., Crowe L.M. Preservation of mammalian cells-learning nature's tricks. Nat. Biotechnol. 2000, 18:145-146.
10. Crowe J.H., Crowe L.M., Chapman D. Preservation of membranes in anhydrobiotic organisms: the role of trehalose. Science 1984, 223:701-703.
11. Crowe J.H., Crowe L.M., Carpenter J.F., Aurell Wistrom C. Stabilization of dry phospholipid bilayers and proteins by sugars. Biochem. J. 1987, 242:1-10.
12. Davis J., Rowley S.D., Santos G.W. Toxicity of autologous bone marrow graft infusion. Prog. Clin. Biol. Res. 1990, 333:531-540.
13. Eroglu A., Toner M., Toth T.L. Beneficial effect of microinjected trehalose on the cryosurvival of human oocytes. Fertil. Steril. 2002, 77:152-158.
14. Garaventa A., Porta F., Rondelli R., Dini G., Meloni G., Bonetti F., Uderzo C., De Manzini A., Miniero R., Brutti F., et al. Early deaths in children after BMT. Bone marrow transplantation group of the Italian association for pediatric hematology and oncology (AIEOP) and gruppo italiano trapianto di midollo osseo (GITMO). Bone Marrow Transplant. 1992, 10:419-423.
15. Gluckman E. Recent trends in allogeneic bone marrow transplantation. Clin. Transpl. 1989, 123-128.
16. Gluckman E., Rocha V. Cord blood transplantation: state of the art. Haematologica 2009, 94:451-454.
17. Green J.L., Driggers B. All visiting nurses are not alike: home health and community health nursing. J. Community Health Nurs. 1989, 6:83-93.
18. Haspel R.L., Miller K.B. Hematopoietic stem cells: source matters. Curr. Stem Cell Res. Ther. 2008, 3:229-236.
19. Holovati J.L., Gyongyossy-Issa M.I., Acker J.P. Effects of trehalose-loaded liposomes on red blood cell response to freezing and post-thaw membrane quality. Cryobiology 2009, 58:75-83.
20. Huang S., Chen Z., Yu J.F., Young D., Bashey A., Ho A.D., Law P. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues. Stem Cells 1999, 17:265-272.
21. Katkova N., Critser J.K., Mazur P. Mouse spermatozoa in high concentrations of glycerol: chemical toxicity vs osmotic shock at normal and reduced oxygen concentrations. Cryobiology 1998, 37:325-338.
22. Kearney J.N. Evaluation of proteinase inhibitors and free radical inhibitors/scavengers in reducing post-thaw viability loss of cryopreserved skin. Burns 1998, 24:507-512.
23. Keeney M., Chin-Yee I., Weir K., Popma J., Nayar R., Sutherland D.R. Single platform flow cytometric absolute CD34+ cellcounts based on the ISHAGE guidelines. International society of hematotherapy and graft engineering. Cytometry 1998, 34:61-70.
24. Kurtzberg J. Umbilical cord blood: a novel alternative source of hematopoietic stem cells for bone marrow transplantation. J. Hematother. 1996, 5:95-96.
25. Laroche V., McKenna D.H., Moroff G., Schierman T., Kadidlo D., McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of post-thaw and post-wash samples. Transfusion 2005, 45:1909-1916.
26. Limaye L.S. Bone marrow cryopreservation: improved recovery due to bioantioxidant additives in the freezing solution. Stem Cells 1997, 15:353-358.
27. Limaye L.S., Kale V.P. Cryopreservation of human hematopoietic cells with membrane stabilizers and bioantioxidants as additives in the conventional freezing medium. J. Hematother. Stem Cell Res. 2001, 10:709-718.
28. Lovelock J.E., Bishop M.W. Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature 1959, 183:1394-1395.
29. Moezzi L., Pourfathollah A.A., Alimoghaddam K., Soleimani M., Ardjmand A.R. The effect of cryopreservation on clonogenic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Transplant. Proc. 2005, 37:4500-4503.
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
31. Okamoto Y., Takaue Y., Saito S., Shimizu T., Suzue T., Abe T., Sato J., Hirao A., Watanabe T., Kawano Y., et al. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993, 33:578-581.
32. Patist A., Zoerb H. Preservation mechanisms of trehalose in food and biosystems. Colloids Surf. B Biointerfaces 2005, 40:107-113.
33. Potts M. Desiccation tolerance of prokaryotes. Microbiol. Rev. 1994, 58:755-805.
34. Richards A.B., Krakowka S., Dexter L.B., Schmid H., Wolterbeek A.P., Waalkens-Berendsen D.H., Shigoyuki A., Kurimoto M. Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem. Toxicol. 2002, 40:871-898.
35. Rocha V., Wagner J.E., Sobocinski K.A., Klein J.P., Zhang M.J., Horowitz M.M., Gluckman E. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources. N. Engl. J. Med. 2000, 342:1846-1854.
36. Rodrigues J.P., Paraguassu-Braga F.H., Carvalho L., Abdelhay E., Bouzas L.F., Porto L.C. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology 2008, 56:144-151.
37. Rubinstein P. Placental blood-derived hematopoietic stem cells for unrelated bone marrow reconstitution. J. Hematother. 1993, 2:207-210.
38. Sasnoor L.M., Kale V.P., Limaye L.S. Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J. Hematother. Stem Cell Res. 2003, 12:553-564.
39. Sasnoor L.M., Kale V.P., Limaye L.S. A combination of catalase and trehalose as additives to conventional freezing medium results in improved cryoprotection of human hematopoietic cells with reference to in vitro migration and adhesion properties. Transfusion 2005, 45:622-633.
40. Sasnoor L.M., Kale V.P., Limaye L.S. Prevention of apoptosis as a possible mechanism behind improved cryoprotection of hematopoietic cells by catalase and trehalose. Transplantation 2005, 80:1251-1260.
41. Sauer-Heilborn A., Kadidlo D., McCullough J. Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004, 44:907-916.
42. Scheinkonig C., Kappicht S., Kolb H.J., Schleuning M. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells. Bone Marrow Transplant. 2004, 34:531-536.
43. Wagner J.E., Barker J.N., DeFor T.E., Baker K.S., Blazar B.R., Eide C., Goldman A., Kersey J., Krivit W., MacMillan M.L., Orchard P.J., Peters C., Weisdorf D.J., Ramsay N.K., Davies S.M. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100:1611-1618.
44. Zambelli A., Poggi G., Da Prada G., Pedrazzoli P., Cuomo A., Miotti D., Perotti C., Preti P., Robustelli della Cuna G. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 1998, 18:4705-4708.